<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Myleodysplastic syndromes (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are pre-malignant hematopoietic diseases that can progress to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) progression in conjunction with changes in immune function </plain></SENT>
<SENT sid="1" pm="."><plain>In this model of <z:hpo ids='HP_0001909'>leukemia</z:hpo> evolution, the expansion of immunosuppressive regulatory T cells (Tregs) contributes to immune escape </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we discuss the importance of Treg-memory phenotype switching as a poor prognostic indicator in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>